# Infusion of Expanded Cord Blood T Cells

> **NCT00972101** · PHASE1 · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Stem Cell Transplantation
- Leukemia
- Lymphoma
- Pediatric Disorders

## Interventions

- **RADIATION:** Total Body Irradiation (TBI)
- **DRUG:** Melphalan
- **DRUG:** Thiotepa
- **DRUG:** Fludarabine
- **DRUG:** Rituximab
- **DRUG:** Etoposide
- **DRUG:** Anti-thymocyte globulin (ATG)
- **DRUG:** Mycophenolate Mofetil (MMF)
- **DRUG:** Tacrolimus
- **PROCEDURE:** Cord Blood Infusion
- **DRUG:** G-CSF
- **PROCEDURE:** Ex vivo expanded T cell Infusion

## Key facts

- **NCT ID:** NCT00972101
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-09
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Development of other studies led to termination without recruitment.
- **Last updated:** 2012-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00972101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00972101, "Infusion of Expanded Cord Blood T Cells". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00972101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*